AI-generated analysis. Always verify with the original filing.
On March 20, 2026, Plus Therapeutics, Inc. appointed Ronald A. Andrews to its Board of Directors to fill the vacancy created by the resignation of Dr. Robert Lenk, who resigned without any disagreement on company matters. Mr. Andrews, an independent director with extensive diagnostics industry experience, was also appointed to the Nominating and Corporate Governance Committee.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment t
Ronald A. Andrews
Effective: 2026-03-20
To fill vacancy created by resignation of Dr. Robert Lenk
Dr. Robert Lenk
Effective: 2026-03-20
Not the result of any disagreement with the Company on any matter relating to operations, policies or practices